Arvinas, Inc. (ARVN)
12.13
-0.07
(-0.57%)
USD |
NASDAQ |
Jan 15, 16:00
12.26
+0.13
(+1.07%)
After-Hours: 07:23
Arvinas SG&A Expense (TTM): 107.00M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Verastem, Inc. | 67.48M |
| Genprex, Inc. | 6.261M |
| Olema Pharmaceuticals, Inc. | 18.61M |